Home » Topics » BioWorld Science

BioWorld Science
RSS

Filgrastim reduces neutropenia and morbidity associated with AML treatment

Jan. 20, 1998

Preclinical efficacy results reported for Maruho's NSAID

Jan. 20, 1998

CVT-313: promising antiproliferative agent that inhibits CDK2

Jan. 20, 1998

Sheffield proceeds with development of respiratory drugs in its MSI

Jan. 20, 1998

Zeneca commits to development of Zomig line extensions

Jan. 20, 1998

New HIV vaccine from VaxGen cleared for phase I/II studies

Jan. 20, 1998

Lovenox/Clexane receives approvals in 11 additional countries

Jan. 20, 1998

Novel gene therapy for chemoprotection of bone marrow found safe in early clinical trials

Jan. 20, 1998

Novel atypical antipsychotic agent presented by Lundbeck

Jan. 20, 1998

VEGF and FGF receptor TK inhibitors from Zeneca

Jan. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...